Dorchester Wealth Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $5.5M | Sell |
122,445
-12,370
| -9% | -$694K | 1.1% | 32 |
|
|
2024
Q3 | $8.48M | Buy |
134,815
+8,340
| +7% | +$487K | 1.55% | 24 |
|
|
2024
Q2 | $7.47M | Buy |
126,475
+112
| +0.1% | +$7.01K | 1.44% | 25 |
|
|
2024
Q1 | $10.1M | Buy |
126,363
+1,975
| +2% | +$151K | 1.81% | 20 |
|
|
2023
Q4 | $9.82M | Buy |
124,388
+5,143
| +4% | +$366K | 1.82% | 19 |
|
|
2023
Q3 | $8.33M | Buy |
119,245
+3,945
| +3% | +$280K | 1.68% | 21 |
|
|
2023
Q2 | $7.97M | Buy |
115,300
+3,175
| +3% | +$226K | 1.62% | 25 |
|
|
2023
Q1 | $8.33M | Buy |
112,125
+6,028
| +6% | +$505K | 1.72% | 22 |
|
|
2022
Q4 | $9.89M | Sell |
106,097
-2,023
| -2% | -$195K | 2.34% | 12 |
|
|
2022
Q3 | $10.3M | Buy |
108,120
+1,645
| +2% | +$163K | 2.27% | 11 |
|
|
2022
Q2 | $9.87M | Buy |
106,475
+360
| +0.3% | +$35.1K | 1.97% | 15 |
|
|
2022
Q1 | $13.4M | Sell |
106,115
-3,624
| -3% | -$381K | 2.15% | 12 |
|
|
2021
Q4 | $11.3M | Sell |
109,739
-1,724
| -2% | -$159K | 2.25% | 11 |
|
|
2021
Q3 | $9.46M | Sell |
111,463
-1,049
| -0.9% | -$87.9K | 2.33% | 11 |
|
|
2021
Q2 | $9.39M | Sell |
112,512
-2,154
| -2% | -$176K | 2.15% | 14 |
|
|
2021
Q1 | $8.63M | Sell |
114,666
-231
| -0.2% | -$16.8K | 2.14% | 14 |
|
|
2020
Q4 | $7.85M | Sell |
114,897
-1,393
| -1% | -$90.6K | 2.08% | 14 |
|
|
2020
Q3 | $6.79M | Buy |
116,290
+1,671
| +1% | +$104K | 2.1% | 12 |
|
|
2020
Q2 | $7.45M | Sell |
114,619
-2,582
| -2% | -$163K | 2.36% | 11 |
|
|
2020
Q1 | $6.95M | Buy |
117,201
+371
| +0.3% | +$24.8K | 2.57% | 10 |
|
|
2019
Q4 | $8.68M | Sell |
116,830
-360
| -0.3% | -$25.3K | 2.42% | 12 |
|
|
2019
Q3 | $7.39M | Buy |
117,190
+8,960
| +8% | +$531K | 2.17% | 14 |
|
|
2019
Q2 | $5.9M | Buy |
108,230
+2,630
| +2% | +$142K | 1.75% | 21 |
|
|
2019
Q1 | $5.7M | Buy |
105,600
+8,680
| +9% | +$536K | 1.74% | 20 |
|
|
2018
Q4 | $6.35M | Buy |
96,920
+1,980
| +2% | +$148K | 2.21% | 14 |
|
|
2018
Q3 | $7.47M | Buy |
94,940
+4,156
| +5% | +$297K | 2.32% | 13 |
|
|
2018
Q2 | $5.84M | Buy |
90,784
+440
| +0.5% | +$29K | 1.92% | 19 |
|
|
2018
Q1 | $5.62M | Buy |
90,344
+4,349
| +5% | +$312K | 1.89% | 18 |
|
|
2017
Q4 | $6.24M | Buy |
85,995
+4,185
| +5% | +$304K | 1.97% | 16 |
|
|
2017
Q3 | $6.65M | Buy |
81,810
+5,254
| +7% | +$416K | 2.14% | 14 |
|
|
2017
Q2 | $6.16M | Buy |
76,556
+6,203
| +9% | +$490K | 2.12% | 14 |
|
|
2017
Q1 | $5.52M | Buy |
70,353
+3,093
| +5% | +$247K | 1.92% | 16 |
|
|
2016
Q4 | $5.31M | Buy |
67,260
+5,790
| +9% | +$468K | 1.93% | 18 |
|
|
2016
Q3 | $5.47M | Buy |
61,470
+1,335
| +2% | +$126K | 2.04% | 15 |
|
|
2016
Q2 | $5.76M | Buy |
60,135
+2,335
| +4% | +$233K | 2.14% | 12 |
|
|
2016
Q1 | $6M | Sell |
57,800
-2,095
| -3% | -$204K | 2.27% | 11 |
|
|
2015
Q4 | $5.86M | Buy |
59,895
+2,545
| +4% | +$249K | 2.43% | 9 |
|
|
2015
Q3 | $7.38M | Buy |
57,350
+990
| +2% | +$104K | 2.73% | 9 |
|
|
2015
Q2 | $7.38M | Buy |
+56,360
| New | +$5.76M | 2.43% | 9 |
|
Other funds holding CVS
Dorchester Wealth Management's CVS Position: Q4 2024 in Review
Dorchester Wealth Management reduced its CVS Health (CVS) stake by 9.2% in Q4 2024, selling an estimated $694K and leaving 122,445 shares worth $5.5M. The position accounts for 1.1% of the portfolio, ranked #32.
Dorchester Wealth Management first reported a position in CVS in Q2 2015 and has held it in 39 quarters since. The position peaked at $13.4M in Q1 2022. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- Dorchester Wealth Management held 122,445 shares of CVS Health worth $5.5M as of Q4 2024.
- Dorchester Wealth Management sold 12,370 CVS Health shares in Q4 2024, an estimated $694K.
- CVS Health made up 1.1% of Dorchester Wealth Management's portfolio in Q4 2024, its #32 holding.
- Dorchester Wealth Management first reported a position in CVS Health in Q2 2015 and has held it in 39 quarters since.
- Dorchester Wealth Management's CVS Health position peaked at $13.4M in Q1 2022.
- 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on Dorchester Wealth Management's 13F filing for Q4 2024, filed 4 Feb 2025.